What Is Junctional Epidermolysis Bullosa, LAMC2-related?

Junctional epidermolysis bullosa (JEB), LAMC2-related is an inherited disease that causes severe blistering on the skin. There are two types of this condition: Herlitz JEB (H-JEB) and non-Herlitz JEB (NH-JEB). Both forms of JEB are caused by mutations in the LAMC2 gene.

Herlitz Junctional Epidermolysis Bullosa

Individuals with H-JEB lack anchors to hold the layers of their skin together. They develop large, fluid-filled blisters in response to any trauma, even something as minor as increased room temperature. Internal blistering on the lining of the nose, mouth, esophagus, trachea, rectum, stomach, intestines, and eyes are also present from birth.

Granulation tissue, a kind of soft, pink, bumpy, moist skin, forms at blistering sites in the healing process. It is also seen around the nose, mouth, ears, fingers, and toes, as well as in areas that receive friction, such as the buttocks and back of the head. Because this tissue can chafe and wear away, it bleeds easily, can be a site of fluid loss, and leave the patient open to infection.

Other symptoms in infants and children with the disease may include a hoarse cry, cough, other breathing problems, fevers, loss of fingernails and toenails, poorly-formed tooth enamel, abnormalities of the urinary tract and bladder (may lead to urinary tract infections and kidney failure), poor growth, electrolyte imbalance, hair loss, osteoporosis, and skin cancer.

Non-Herlitz Junctional Epidermolysis Bullosa

NH-JEB is a less severe form of H-JEB. Blistering occurs in fewer areas (hands, feet, knees, and elbows), and may not result in blistering of the internal organs. The onset of blistering may be later as well. Issues related to granulation tissue and complications with breathing are not common. However, hair loss, improper nail formation, and poorly formed tooth enamel are seen.

How Common Is Junctional Epidermolysis Bullosa, LAMC2-related?

H-JEB is extremely rare. Overall estimates indicate that 0.37 individuals per million are affected by H-JEB.

NH-JEB is slightly more common, with overall estimates of 2 individuals per million being affected by the disease.

How Is Junctional Epidermolysis Bullosa, LAMC2-related treated?

Symptoms are generally treated as they arise. It is best to protect the child as much as possible from skin damage. For example, a cesarean section may be recommended to protect the child from the skin trauma of birth, excess movement is avoided, and clothing that may damage the skin is avoided. When open wounds and blistered skin occur, they are often covered with multiple layers of non-adhesive bandages and anyone handling the child must use extreme care.

Antibiotics are often prescribed for infection, and antiseptics are often used to prevent infection. For individuals with H-JEB, a dietitian should be consulted for an infant's proper nutrition. To avoid dehydration, these children should also drink plenty of fluids.

In individuals with breathing difficulty (more typically associated with H-JEB), an opening may be made in the neck to deliver air to the trachea. However, this may be difficult on an individual with fragile skin.

What Is the Prognosis for a Person with Junctional Epidermolysis Bullosa, LAMC2-related?

The prognosis for individuals with H-JEB or NH-JEB is poor and roughly 40-45% of individuals with either form of JEB die in the first year of life. Roughly 62% of individuals with H-JEB and 48% of individuals with NH-JEB die by age 15. This disease is extremely painful and causes of death often include impaired physical growth (failure to thrive), infection, and respiratory failure.

Other names for
junctional epidermolysis bullosa, LAMC2-related

  • Epidermolysis bullosa junctional, Herlitz-Pearson type
  • Herlitz junctional epidermolysis bullosa, LAMC2-related
  • Junctional epidermolysis bullosa
  • LAMC2-related junctional epidermolysis bullosa


  • Aberdam et al., 1994, Nat Genet, 6(3):299-304, PMID: 8012394
  • Fine et al., 2014, J Am Acad Dermatol, 70(6):1103-26, PMID: 24690439
  • Online Mendelian Inheritance in Man, OMIM [226650], 2016, http://omim.org/entry/226650?search=226700&highlight=226650
  • Online Mendelian Inheritance in Man, OMIM [226700], 2009, http://omim.org/entry/226700?search=226700&highlight=226700
  • Pfendner et al., 2014, http://www.ncbi.nlm.nih.gov/books/NBK1125/
  • Posteraro et al., 2004, J Invest Dermatol, 123(4):639-48, PMID: 15373767